UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934 (Amendment No. )
| ☑ | Filed by the Registrant | ☐ | Filed by a party other than the Registrant |
| CHECK THE APPROPRIATE BOX: | ||
| ☐ | Preliminary Proxy Statement | |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
| ☐ | Definitive Proxy Statement | |
| ☑ | Definitive Additional Materials | |
| ☐ | Soliciting Material under §240.14a-12 | |
United Therapeutics Corporation
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
| PAYMENT OF FILING FEE (CHECK ALL BOXES THAT APPLY): | ||
| ☑ | No fee required | |
| ☐ | Fee paid previously with preliminary materials | |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 | |
| | |||||||
| |
| Your Vote Counts! UNITED THERAPEUTICS CORPORATION 2023 Annual Meeting
| |||||
| | |||||||
| |
| ||||||
V13537-P93776 | |||||||
You invested in UNITED THERAPEUTICS CORPORATION and it’s time to vote!
You have the right to vote on proposals being presented at the Annual Meeting. THIS IS AN IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIAL FOR THE SHAREHOLDER MEETING TO BE HELD ON JUNE 26, 2023.
Get informed before you vote
View the Notice and Proxy Statement and Annual Report on Form 10-K online OR you can receive a free paper or email copy of the material(s) by requesting prior to June 12, 2023. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.
 | For complete information and to vote, visit www.ProxyVote.com | ||||
Control # | |||||
Smartphone users Point your camera here and |  | Vote Virtually at the Meeting* Location: Virtual Annual Meeting of Shareholders conducted | ||
| ||||
| * | Please check the meeting materials for any special requirements for meeting attendance. |
| Vote at www.ProxyVote.com |
| THIS IS NOT A VOTABLE BALLOT | |
You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting. Please follow the instructions on the reverse side to vote these important matters. |
| Voting Items | Board | ||
| 1. | Election of Directors | ||
| Nominees: | ||
1a. | Christopher Causey |  | For |
1b. | Raymond Dwek | | For |
1c. | Richard Giltner | | For |
1d. | Katherine Klein | | For |
1e. | Ray Kurzweil | | For |
1f. | Linda Maxwell | | For |
1g. | Nilda Mesa | | For |
1h. | Judy Olian | | For |
| 1i. | Christopher Patusky | | For |
1j. | Martine Rothblatt | | For |
| 1k. | Louis Sullivan | | For |
| 1l. | Tommy Thompson | | For |
| 2. | Advisory resolution to approve executive compensation. | | For |
| 3. | Advisory vote on the frequency of future advisory votes on executive compensation. |  | Year |
| 4. | Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock Incentive Plan. | | For |
| 5. | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2023. | | For |
| NOTE: Such other business as may properly come before the meeting or any adjournment thereof. | |||
| | |||
| Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. |
V13538-P93776